Clorox upgraded to Neutral at BofA with

As previously reported, BofA upgraded Clorox to Neutral from Underperform with a price target of $150, up from $120. The firm sees a recovery in volume and shelf space taking shape as a recovery from the cybersecurity attack takes hold. The firm expects this to allow Clorox to return to its annual growth rate of 3%-5% in FY25/FY26, the analyst tells investors.